Upload
PPT-Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

PPT-Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses

Author : davis | Published Date : 2024-09-06

FernandezGarcia M Majumdar M Kebe O Fall AD Kone M Kande M et al Emergence of VaccineDerived Polioviruses during Ebola Virus Disease Outbreak Guinea 20142015 Emerg

vaccine 2015 case ebola vaccine ebola case contacts circles paralysis derived emergence onset opv polio patients laboratory

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure 1 Figure 1. Epidemiologic context..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses: Transcript

FernandezGarcia M Majumdar M Kebe O Fall AD Kone M Kande M et al Emergence of VaccineDerived Polioviruses during Ebola Virus Disease Outbreak Guinea 20142015 Emerg Infect Dis 20182416574 httpsdoiorg103201eid2401171174. -1- Figure 1 -2- Figure 3 Figure 4 Figure 5loss resistance is zero, and that the radiation resistance is the textbook figure of 35 ohms. The feedpointimpedance would then be 15+0+35 = 50 ohms, and th Pandemics and Emerging Infections. Sarah Gilbert, Jenner Institute, University of Oxford. THE JENNER INSTITUTE. a partnership between Oxford University and . the . Pirbright. Institute . - Developing innovative vaccines. February 2015Vaccine-associated paralytic polio VAPP and vaccine-derived poliovirus VDPV The oral polio vaccine OPV is an extremely safe and effectivetool for immunizing children against polioOver the Fischer RJ, Judson SD, Miazgowicz K, Bushmaker T, Munster VJ. Ebola Virus Persistence in Semen Ex Vivo. Emerg Infect Dis. 2016;22(2):289-291. https://doi.org/10.3201/eid2202.151278. Minetti A, Kagoli M, Katsulukuta A, Huerga H, Featherstone A, Chiotcha H, et al. Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi. Emerg Infect Dis. 2013;19(2):202-209. https://doi.org/10.3201/eid1902.120301. Wawina-Bokalanga T, Vanmechelen B, Lhermitte V, Martí-Carreras J, Vergote V, Koundouno F, et al. Human Diversity of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen Class I Alleles and Ebola Virus Disease Outcomes. Emerg Infect Dis. 2021;27(1):76-84. https://doi.org/10.3201/eid2701.202177. Jones TF, Buckingham SC, Bopp CA, Ribot E, Schaffner W. From Pig to Pacifier: Chitterling-Associated Yersiniosis Outbreak among Black Infants. Emerg Infect Dis. 2003;9(8):1007-1009. https://doi.org/10.3201/eid0908.030103. Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison T, et al. Accelerating Control of Pertussis in England and Wales. Emerg Infect Dis. 2012;18(1):38-47. https://doi.org/10.3201/eid1801.110784. Shoemaker T, MacNeil A, Balinandi S, Campbell S, Wamala J, McMullan LK, et al. Reemerging Sudan Ebola Virus Disease in Uganda, 2011. Emerg Infect Dis. 2012;18(9):1480-1483. https://doi.org/10.3201/eid1809.111536. Beck LR, Lobitz BM, Wood BL. Remote Sensing and Human Health: New Sensors and New Opportunities. Emerg Infect Dis. 2000;6(3):217-227. https://doi.org/10.3201/eid0603.000301. Scott JT, Sesay FR, Massaquoi TA, Idriss BR, Sahr F, Semple MG. Post-Ebola Syndrome, Sierra Leone. Emerg Infect Dis. 2016;22(4):641-646. https://doi.org/10.3201/eid2204.151302. Chiu RW, Chim SS, Tong Y, Fung KS, Chan P, Zhao G, et al. Tracing SARS-Coronavirus Variant with Large Genomic Deletion. Emerg Infect Dis. 2005;11(1):168-170. https://doi.org/10.3201/eid1101.040544. Chancellor JR, Padmanabhan SP, Greenough TC, Sacra R, Ellison RT, Madoff LC, et al. Uveitis and Systemic Inflammatory Markers in Convalescent Phase of Ebola Virus Disease. Emerg Infect Dis. 2016;22(2):295-297. https://doi.org/10.3201/eid2202.151416. Haddock E, Feldmann F, Feldmann H. Effective Chemical Inactivation of Ebola Virus. Emerg Infect Dis. 2016;22(7):1292-1294. https://doi.org/10.3201/eid2207.160233.

Download Document

Here is the link to download the presentation.
"Figure 1 Figure 1. Epidemiologic context for emergence of vaccine-derived polioviruses"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Ebola: Progress with Vaccines

Ebola: Progress with Vaccines
Fact Sheet

Fact Sheet
Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,

Figure 1 Figure 1. A) Standard curves of Ebola virus spiked into 3 matrices: semen, blood,
Figure 3 Figure 3. . Age distribution of children with measles reported in Malawi, 2010.

Figure 3 Figure 3. . Age distribution of children with measles reported in Malawi, 2010.
Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,

Figure 2 Figure 2. HLA haplotypes identified among the control group, Ebola survivors,
Figure 1 Figure 1. Epidemiologic curve of Yersinia enterocolitica outbreak in

Figure 1 Figure 1. Epidemiologic curve of Yersinia enterocolitica outbreak in
Figure 1 Figure 1. Changes to routine childhood pertussis immunization programs

Figure 1 Figure 1. Changes to routine childhood pertussis immunization programs
Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata

Figure 1 Figure 1. . . Sudan Ebola virus in Uganda, 2011. A) Geographic locations of Nakisimata
Figure 1 Figure 1. Landsat Thematic Mapper (TM) satellite data for a 6x6-km area

Figure 1 Figure 1. Landsat Thematic Mapper (TM) satellite data for a 6x6-km area
Figure 2 Figure 2. Comparison of the most common post-Ebola syndrome symptoms with admission

Figure 2 Figure 2. Comparison of the most common post-Ebola syndrome symptoms with admission
Figure Figure. Schematic illustration of the epidemiologic relationships between

Figure Figure. Schematic illustration of the epidemiologic relationships between
Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United

Figure 1 Figure 1. Slit lamp examination of the left eye of a physician from the United
Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival

Figure Figure. Ebola virus inactivation results as tested in BALB/c mouse model. A) Survival